Replies to post #2653 on RedHill Biopharma Ltd (RDHL)

[DorseyE]

Another pearl in the article.......
Notably, apart from COVID-19, opaganib is being evaluated in a phase IIa study for treating advanced cholangiocarcinoma and in a phase II study for addressing prostate cancer.

Seems the market isn’t listening at the moment.